Events & Presentations
August 2nd -5th, Four Seasons Resort, Napa Valley, California
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
Breakout Session hosted by: Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX, Inc., Perseus SENOLYTIX, Inc. and Ponce Aurora, Inc. (limited attendance available) Reserve your spot
October 21st to 23rd, Berlin
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
Dr. Slawin’s industry keynote address, “Building on the Foundation of Four: Advancing Mitochondrial‑Targeted Geropeptide Medicine” will directly follow Dr. Hazel H. Szeto’s historic academic keynote address, “From Mitochondrial Discovery to Approved Therapy:...
June 5th, 2026 - Royal Sonesta New Orleans
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
Platform Technologies Panel: Obesity & Cardiovascular-Kidney-Metabolic Disease Kevin Slawin, M.D., Founder and CEO Eos SENOLYTIX Presentation to Follow Panel Participation: 01:30 PM, 5th of June - Track B - Room...
May 14th-17th 2026 - Lighthaven, Berkeley CA
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
Vitalist Bay Deep Dive Pitches May 15th, 2026 05:30PM to 06:30PM Vitalist Bay – Longevity’s New Capital
September 16 - 19, 2025, Rome, Italy
Presenter: Kevin Slawin, M.D., Founder and CEO, Eos SENOLYTIX
Phaedon Institute is honored to co-host the 2nd Senotherapeutics Summit alongside the 10th Annual ICSA Conference. This landmark gathering will take place September 16th–19th at the prestigious National Research Council (CNR) in Rome, Italy. Bringing…
© 2026 Perseus SENOLYTIX.